Coya Therapeutics (COYA) Other Working Capital Changes (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Other Working Capital Changes data on file, last reported at -$578196.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 81.5% year-over-year to -$578196.0; the trailing twelve-month figure through Mar 2026 stood at -$304588.0 (up 90.19% YoY), and the FY2025 full-year result was -$2.9 million, down 1063.86% from the prior year.
• Other Working Capital Changes climbed to -$578196.0 in Q1 2026, from -$3.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $2.5 million in Q3 2025 to a low of -$3.1 million in Q1 2025.
• A 5-year average of -$149774.8 and a median of -$7426.0 in 2022 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 3579.79% in 2025, while the deepest fall reached 157004.51% in 2025.
• Tracing COYA's Other Working Capital Changes over 5 years: stood at $1.2 million in 2022, then slumped by 88.86% to $133203.0 in 2023, then slumped by 101.47% to -$1952.0 in 2024, then sank by 157004.51% to -$3.1 million in 2025, then surged by 81.15% to -$578196.0 in 2026.
• Business Quant data shows COYA's Other Working Capital Changes at -$578196.0 in Q1 2026, -$3.1 million in Q4 2025, and $2.5 million in Q3 2025.